lamivudine has been researched along with oligonucleotides in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goto, M; Hamasaki, N; Kamiya, N; Kuma, H; Maruyama, T; Park, LC | 1 |
Jeon, WK; Kim, BI; Kim, YJ; Park, H; Woo, HY | 1 |
Dugange, F; Harms, G; Hauser, A; Kuecherer, C; Kunz, A; Lau, I; Mbezi, P; Sewangi, J; Theuring, S; Ziske, J | 1 |
Baik, SK; Chae, HB; Hong, SP; Kim, CW; Kim, JH; Kim, MY; Kim, YS; Lee, CD; Lee, JI; Lee, JW; Lee, MS; Park, CK; Park, SH; Seo, YS; Um, SH; Yim, HJ; Yoon, EL | 1 |
Chen, H; Chen, J; Jiang, L; Li, D; Lin, J; Ou, Q; Su, M; Wang, W; Yang, B; Zeng, Y | 1 |
Beck, IA; Frenkel, LM; Jourdain, G; Khamduang, W; Laomanit, L; Ngo-Giang-Huong, N; Payant, R | 1 |
1 trial(s) available for lamivudine and oligonucleotides
Article | Year |
---|---|
Adding adefovir vs. switching to entecavir for lamivudine-resistant chronic hepatitis B (ACE study): a 2-year follow-up randomized controlled trial.
Topics: Adenine; Adult; Analysis of Variance; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B, Chronic; Humans; Immunoassay; Lamivudine; Male; Middle Aged; Oligonucleotides; Organophosphonates; Prospective Studies; Republic of Korea; Reverse Transcriptase Inhibitors; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Treatment Outcome | 2013 |
5 other study(ies) available for lamivudine and oligonucleotides
Article | Year |
---|---|
Mutation detection in the drug-resistant hepatitis B virus polymerase gene using nanostructured reverse micelles.
Topics: Anti-HIV Agents; Hepatitis B virus; In Situ Hybridization; Indicators and Reagents; Lamivudine; Micelles; Oligonucleotides; RNA-Directed DNA Polymerase; Spectrophotometry, Ultraviolet | 2004 |
Evaluation of dual priming oligonucleotide-based multiplex PCR for detection of HBV YMDD mutants.
Topics: Adult; Aged; DNA Primers; Drug Resistance, Viral; Female; Genotype; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Oligonucleotides; Polymerase Chain Reaction | 2008 |
Emergence of minor drug-resistant HIV-1 variants after triple antiretroviral prophylaxis for prevention of vertical HIV-1 transmission.
Topics: Adult; Alleles; Anti-Retroviral Agents; Drug Resistance, Viral; Female; Genetic Variation; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Mutation; Nevirapine; Oligonucleotides; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Tanzania; Zidovudine | 2012 |
Establishment of real time allele specific locked nucleic acid quantitative PCR for detection of HBV YIDD (ATT) mutation and evaluation of its application.
Topics: Adenine; Adult; Alleles; Antiviral Agents; DNA Primers; DNA, Viral; Drug Resistance, Viral; Early Diagnosis; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Isoleucine; Lamivudine; Limit of Detection; Male; Middle Aged; Molecular Sequence Data; Mutation; Nucleotide Motifs; Oligonucleotides; Organophosphonates; Real-Time Polymerase Chain Reaction | 2014 |
Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus.
Topics: Antiviral Agents; Cloning, Molecular; Drug Resistance, Viral; Genes, Viral; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Microbial Sensitivity Tests; Mutation; Oligonucleotides | 2016 |